Novel interaction of apolipoprotein(a) with beta-2 glycoprotein I mediated by the kringle IV domain

Blood. 1997 Aug 15;90(4):1482-9.


Lipoprotein(a) [Lp(a)], which has been shown to interact with fibrin(ogen) and other components of the blood clotting cascade, is a major independent risk factor for atherothrombotic disease in humans. The physiological function(s) of Lp(a), as well as the precise mechanism(s) by which high plasma levels of Lp(a) increase risk are unknown. Identification of further potential apo(a)-protein ligands may be crucial to illuminate apo(a)'s function(s) and pathophysiological properties. We used the repetitive apo(a) kringle IV type 2, which is variable in number in apo(a), to screen a human liver cDNA library by the yeast two-hybrid interaction trap system. Among 11 positive clones that emerged from the screen, eight clones were identified as beta-2 glycoprotein I and one as fibronectin. Coimmunoprecipitation experiments confirmed that beta-2 glycoprotein I and apo(a)/Lp(a) interact in human plasma and in cell culture supernatants of COS-1 cells, which ectopically expressed apo(a). The apo(a)-beta2-glycoprotein I interaction indicates new potential roles for Lp(a) in fibrinolysis and autoimmunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apolipoproteins / metabolism*
  • Apoprotein(a)
  • Binding Sites
  • Calmodulin-Binding Proteins / metabolism*
  • Cell Line
  • Enzyme-Linked Immunosorbent Assay
  • Glycoproteins / metabolism*
  • Humans
  • Kringles*
  • Ligands
  • Lipoprotein(a) / metabolism*
  • Lipoproteins, LDL / metabolism
  • Liver / metabolism
  • Membrane Glycoproteins / metabolism*
  • Protein Binding
  • Saccharomyces cerevisiae
  • beta 2-Glycoprotein I


  • Apolipoproteins
  • Calmodulin-Binding Proteins
  • Glycoproteins
  • Ligands
  • Lipoprotein(a)
  • Lipoproteins, LDL
  • Membrane Glycoproteins
  • beta 2-Glycoprotein I
  • Apoprotein(a)